Strange Tony,
It's been one week since Humana and two financial rapscallions purchased Kindred at Home, the Old Gentiva plus Integracare and Professional Medical's home health and hospice agencies. There's a slight unease at our hospice. We've not seen hide nor hair of VP Toad.
With the Curo Health Services buyout looming I expect Kindred hospice area/regional managers are rather nervous. Our new owners plan to put Kindred's hospice division under Curo, despite our having nearly twice the revenue and much larger hospices by volume. Their rationale is Curo's management is more entrepreneurial.
Curo Health Services, Inc. have agreed to pay $12.21 million to resolve allegations that they violated the False Claims Act by paying kickbacks in exchange for patient referrals.
Curo's leaders settled for $12.2 million with the U.S. Department of Justice in April 2017.
First, from 2007 through 2012, kickbacks were allegedly paid to American Physician Housecalls, a physician housecall company, in exchange for patient referrals to these hospice companies. The alleged kickbacks took the form of sham loans, a free equity interest in another entity, stock dividends, and free rental space.
Second, from 2007 through 2014, kickbacks were allegedly paid to medical providers, including doctors and nurses as well as hospitals and long-term care facilities, in exchange for patient referrals to these hospice companies. The alleged kickbacks took the form of cash, gift cards, and other valuable items.
Hospice employees don't have the means to offer sham loans, free equity, stock dividends or free rental space. Those are all the auspices of management.
Curo spent years under the ownership of financial rapscallions. Their executives are well trained in giving sponsors what they want, steady streams of cash and a huge final payday.
What changes await our hospice? Is Toad Curo material? I sense they share the same distorted values but only so many area/regional managers are needed in the combined company.
Anonymous (from KAHtivacare Hospice)
No comments:
Post a Comment